Argitalpenak (33) Alfredo Ginés Casanova Paso argitalpenak

2023

  1. Caracterización funcional del daño renal asociado a la inmunoterapia oncológica

    Farmajournal, Vol. 8, Núm. 1, pp. 7-19

  2. Identification of Pre-Renal and Intrinsic Acute Kidney Injury by Anamnestic and Biochemical Criteria: Distinct Association with Urinary Injury Biomarkers

    International journal of molecular sciences, Vol. 24, Núm. 3

  3. New Challenges in the Diagnosis of Kidney Damage Due to Immune Checkpoint Inhibitors Therapy: An Observational Clinical Study

    Diagnostics, Vol. 13, Núm. 15

  4. “Adivina el envenenamiento”: un juego para aprender toxicología a través de Instagram

    Farmajournal, Vol. 8, Núm. 2, pp. 39-40

2022

  1. Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application

    Journal of Personalized Medicine, Vol. 12, Núm. 7

  3. Evaluación histológica del daño renal producido por los inhibidores del punto de control inmunitario

    Farmajournal, Vol. 7, Núm. 2, pp. 53-65

  4. Neural Network-Based Calculator for Rat Glomerular Filtration Rate

    Biomedicines, Vol. 10, Núm. 3

  5. Protective Effect of Quercetin 3-O-Glucuronide against Cisplatin Cytotoxicity in Renal Tubular Cells

    Molecules, Vol. 27, Núm. 4

2021

  1. A micellar formulation of quercetin prevents cisplatin nephrotoxicity

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-14

  2. Adverse health effects in women farmers indirectly exposed to pesticides

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 11

  3. Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 21

  4. Are antioxidants useful in preventing the progression of chronic kidney disease?

    Antioxidants, Vol. 10, Núm. 11

  5. Detección del riesgo de lesión renal en fumadores

    Farmajournal, Vol. 6, Núm. 2, pp. 49-62

  6. Regression modeling of the antioxidant-to-nephroprotective relation shows the pivotal role of oxidative stress in cisplatin nephrotoxicity

    Antioxidants, Vol. 10, Núm. 9

  7. The furosemide stress test and computational modeling identify renal damage sites associated with predisposition to acute kidney injury in rats

    Translational Research, Vol. 231, pp. 76-91

  8. Urinary Plasminogen Activator Inhibitor-1: A Biomarker of Acute Tubular Injury

    American Journal of Nephrology, Vol. 52, Núm. 9, pp. 714-724

2020

  1. A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application

    Critical Reviews in Toxicology, Vol. 50, Núm. 9, pp. 780-800

  2. Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury

    Scientific Reports, Vol. 10, Núm. 1

  3. Corrigendum to ‘P-Glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: Ex vivo and in vivo studies’ [Toxicology and Applied Pharmacology 386 (2020) 114832] (Toxicology and Applied Pharmacology (2020) 386, (S0041008X19304405), (10.1016/j.taap.2019.114832))

    Toxicology and Applied Pharmacology